Tianjin Lisheng Pharmaceutical Co.,Ltd.

Shenzhen Stock Exchange 002393.SZ

Tianjin Lisheng Pharmaceutical Co.,Ltd. Receivables for the year ending December 31, 2023: USD 44.02 M

Tianjin Lisheng Pharmaceutical Co.,Ltd. Receivables is USD 44.02 M for the year ending December 31, 2023, a -21.71% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Tianjin Lisheng Pharmaceutical Co.,Ltd. Receivables for the year ending December 31, 2022 was USD 56.22 M, a -13.71% change year over year.
  • Tianjin Lisheng Pharmaceutical Co.,Ltd. Receivables for the year ending December 31, 2021 was USD 65.16 M, a 8.04% change year over year.
  • Tianjin Lisheng Pharmaceutical Co.,Ltd. Receivables for the year ending December 31, 2020 was USD 60.31 M, a 7.97% change year over year.
  • Tianjin Lisheng Pharmaceutical Co.,Ltd. Receivables for the year ending December 31, 2019 was USD 55.86 M, a -12.44% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
Loading...
Shenzhen Stock Exchange: 002393.SZ

Tianjin Lisheng Pharmaceutical Co.,Ltd.

CEO Mr. Fujun Wang
IPO Date April 23, 2010
Location China
Headquarters No.16, Saida North 1st Road
Employees 1,328
Sector Health Care
Industries
Description

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the production and sale of chemical medicines. The company offers tablets, hard capsules, dripping pills, freeze-dried powder injections, water injections, and bulk medicines, as well as intermediates, diagnostic reagents, biochemical reagents, and plastic bottles. It also exports its products. The company is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Pharmaceutical Holdings Co., Ltd.

Similar companies

002437.SZ

Harbin Gloria Pharmaceuticals Co., Ltd

USD 0.34

5.49%

002332.SZ

Zhejiang Xianju Pharmaceutical Co.,Ltd.

USD 1.34

1.98%

002349.SZ

Jinghua Pharmaceutical Group Co., Ltd.

USD 1.01

2.22%

StockViz Staff

January 15, 2025

Any question? Send us an email